5 Heart Failure Clinical Trials in Alexander City, AL (2026)

Q: How do I join a clinical trial in Alexander City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Alexander City research site will contact you.

Recruiting Heart Failure Studies in Alexander City

NCT06307652Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function...

Alexander City, ALPHASE34,800 participantsAstraZeneca

View Study Details

NCT02901184Recruiting

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldo...

Alexander City, ALPHASE32,000 participantsUppsala University

View Study Details

NCT06736574Recruiting

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

The purpose of this study is to find out if the investigational drug called omecamtiv mecarbil can reduce the risk of the effects of heart failure, like hospitalization, transplantation, or death in p...

Alexander City, ALPHASE31,800 participantsCytokinetics

View Study Details

NCT06200207Recruiting

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

The study is being done to see if ziltivekimab can be used to treat participants living with heart failure and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (ina...

Alexander City, ALPHASE3680 participantsNovo Nordisk A/S

View Study Details

NCT07288398Recruiting

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with p...

Alexander City, ALPHASE3540 participantsTenax Therapeutics, Inc.

View Study Details

About Heart Failure Clinical Trials in Alexander City

Heart failure is a chronic condition where the heart cannot pump blood efficiently to meet the body's needs. It affects millions of people worldwide and can result from various heart conditions. Treatment includes medications, lifestyle changes, devices, and in severe cases, heart transplant.

There are currently 5 heart failure clinical trials recruiting participants in Alexander City, AL. These studies are seeking a combined 9,820 participants. Research is being sponsored by AstraZeneca, Uppsala University, Cytokinetics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Failure Clinical Trials in Alexander City — FAQ

Are there heart failure clinical trials in Alexander City?

Yes, there are 5 heart failure clinical trials currently recruiting in Alexander City, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Alexander City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Alexander City research site will contact you about next steps.

Are clinical trials in Alexander City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Alexander City studies also compensate for your time and travel.

What heart failure treatments are being tested?

The 5 active trials in Alexander City are testing new therapies including novel drugs, biologics, and treatment approaches for heart failure.

Data updated July 22, 2026 from ClinicalTrials.gov